摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ROCHE screening, 75

中文名称
——
中文别名
——
英文名称
ROCHE screening, 75
英文别名
(5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylimino)-1,3-oxazolidin-4-one
ROCHE screening, 75化学式
CAS
——
化学式
C18H13N3O2S
mdl
——
分子量
335.386
InChiKey
RVOPXDLRTRUOFB-YBEGLDIGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    91.8
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    喹啉-6-甲醛sodium acetate溶剂黄146N,N-二异丙基乙胺 作用下, 以 乙醇 为溶剂, 反应 24.17h, 生成 ROCHE screening, 75
    参考文献:
    名称:
    Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors
    摘要:
    A novel series of quinolinyl-methylene-thiazolinones has been identified as potent and selective cyclin-dependent kinase I (CDK1) inhibitors. Their synthesis and structure activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK1 activity in vitro, and block cell cycle progression in human tumor cell lines, suggesting a potential use as antitumor agents. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.01.081
点击查看最新优质反应信息

文献信息

  • Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors
    作者:Shaoqing Chen、Li Chen、Nam T. Le、Chunlin Zhao、Achyutharao Sidduri、Jian Ping Lou、Christophe Michoud、Louis Portland、Nicole Jackson、Jin-Jun Liu、Fred Konzelmann、Feng Chi、Christian Tovar、Qing Xiang、Yingsi Chen、Yang Wen、Lyubomir T. Vassilev
    DOI:10.1016/j.bmcl.2007.01.081
    日期:2007.4
    A novel series of quinolinyl-methylene-thiazolinones has been identified as potent and selective cyclin-dependent kinase I (CDK1) inhibitors. Their synthesis and structure activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK1 activity in vitro, and block cell cycle progression in human tumor cell lines, suggesting a potential use as antitumor agents. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多